Advertisement
News
Advertisement

Chimerix Appoints Timothy W. Trost Senior Vice President, Chief Financial Officer

Mon, 03/28/2011 - 6:33am
Bio-Medicine.Org

DURHAM, N.C., March 28, 2011 /PRNewswire/ -- Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, announced today that Timothy W. Trost has joined the company as Senior Vice President, Chief Financial Officer.

Mr. Trost brings to Chimerix more than 30 years of experience working in the financial field, combining strong executive management skills with an extensive financial background.  In this newly-created position, Mr. Trost will be responsible for overseeing the company's financial operations, reporting to Kenneth I. Moch, Chimerix's President and Chief Executive Officer.

"Tim is a seasoned industry executive whose depth and breadth of leadership experience significantly strengthen the Chimerix management team," said Mr. Moch. "Tim has been consulting for Chimerix since last fall and has been an important part of the team in securing both the recently announced Series F financing as well as the BARDA contract."

Prior to joining Chimerix, Mr. Trost was Vice President and CFO at Argos Therapeutics, Inc., a venture-backed immunotherapy company located in Research Triangle Park.  Previously, he was Senior Vice President and CFO at InteCardia, Inc., a venture-backed cardiac imaging company.  While at InteCardia, Mr. Trost played a key role in negotiating and executing the sale of the company to Syncor International Corporation. Prior to InteCardia, Mr. Trost served as Executive Vice President and CFO of Coastal Physician Group, Inc., a contract provider of emergency room physicians, having joined the company as Vice President of Corporate Development.  He also held the positions of Vice President of Finance at Morganite North America, Inc., and Senior Manager at Price Waterhouse.  Mr. Trost holds a B.S. in Accounting from the University of Illinois at Urbana-Champaign and is a Certified Public Accountant.

About Chimerix

Chimerix is developing novel ant

'/>"/>

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading